828 related articles for article (PubMed ID: 25043044)
1. PVT1 dependence in cancer with MYC copy-number increase.
Tseng YY; Moriarity BS; Gong W; Akiyama R; Tiwari A; Kawakami H; Ronning P; Reuland B; Guenther K; Beadnell TC; Essig J; Otto GM; O'Sullivan MG; Largaespada DA; Schwertfeger KL; Marahrens Y; Kawakami Y; Bagchi A
Nature; 2014 Aug; 512(7512):82-6. PubMed ID: 25043044
[TBL] [Abstract][Full Text] [Related]
2. Expanding the functional role of long noncoding RNAs.
Johnsson P; Morris KV
Cell Res; 2014 Nov; 24(11):1284-5. PubMed ID: 25104732
[TBL] [Abstract][Full Text] [Related]
3. MYC and PVT1 synergize to regulate RSPO1 levels in breast cancer.
Sarver AL; Murray CD; Temiz NA; Tseng YY; Bagchi A
Cell Cycle; 2016; 15(7):881-5. PubMed ID: 26889781
[TBL] [Abstract][Full Text] [Related]
4. Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma.
Riquelme E; Suraokar MB; Rodriguez J; Mino B; Lin HY; Rice DC; Tsao A; Wistuba II
J Thorac Oncol; 2014 Jul; 9(7):998-1007. PubMed ID: 24926545
[TBL] [Abstract][Full Text] [Related]
5. PVT1: a rising star among oncogenic long noncoding RNAs.
Colombo T; Farina L; Macino G; Paci P
Biomed Res Int; 2015; 2015():304208. PubMed ID: 25883951
[TBL] [Abstract][Full Text] [Related]
6. High amplification of PVT1 and MYC predict favorable prognosis in early ovarian carcinoma.
Yamamoto A; Kurata M; Yamamoto K; Nogawa D; Inoue M; Ishibashi S; Ikeda M; Miyasaka N; Kitagawa M
Pathol Res Pract; 2020 Nov; 216(11):153175. PubMed ID: 32841774
[TBL] [Abstract][Full Text] [Related]
7. Effect of MYC and PARP Inhibitors in Ovarian Cancer Using an
Morea A; Saravi S; Sisu C; Hall M; Tosi S; Karteris E; Storlazzi CT
Anticancer Res; 2024 May; 44(5):1817-1827. PubMed ID: 38677725
[TBL] [Abstract][Full Text] [Related]
8. Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer.
Reiter RE; Sato I; Thomas G; Qian J; Gu Z; Watabe T; Loda M; Jenkins RB
Genes Chromosomes Cancer; 2000 Jan; 27(1):95-103. PubMed ID: 10564591
[TBL] [Abstract][Full Text] [Related]
9. The identification of microRNAs in a genomically unstable region of human chromosome 8q24.
Huppi K; Volfovsky N; Runfola T; Jones TL; Mackiewicz M; Martin SE; Mushinski JF; Stephens R; Caplen NJ
Mol Cancer Res; 2008 Feb; 6(2):212-21. PubMed ID: 18314482
[TBL] [Abstract][Full Text] [Related]
10. The PVT1-MYC duet in cancer.
Tseng YY; Bagchi A
Mol Cell Oncol; 2015; 2(2):e974467. PubMed ID: 27308428
[TBL] [Abstract][Full Text] [Related]
11. The expression pattern of long non-coding RNA PVT1 in tumor tissues and in extracellular vesicles of colorectal cancer correlates with cancer progression.
Guo K; Yao J; Yu Q; Li Z; Huang H; Cheng J; Wang Z; Zhu Y
Tumour Biol; 2017 Apr; 39(4):1010428317699122. PubMed ID: 28381186
[TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression.
Wan L; Sun M; Liu GJ; Wei CC; Zhang EB; Kong R; Xu TP; Huang MD; Wang ZX
Mol Cancer Ther; 2016 May; 15(5):1082-94. PubMed ID: 26908628
[TBL] [Abstract][Full Text] [Related]
13. Amplification and the clinical significance of circulating cell-free DNA of PVT1 in breast cancer.
Li X; Chen W; Wang H; Wei Q; Ding X; Li W
Oncol Rep; 2017 Jul; 38(1):465-471. PubMed ID: 28534994
[TBL] [Abstract][Full Text] [Related]
14. Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element.
Cho SW; Xu J; Sun R; Mumbach MR; Carter AC; Chen YG; Yost KE; Kim J; He J; Nevins SA; Chin SF; Caldas C; Liu SJ; Horlbeck MA; Lim DA; Weissman JS; Curtis C; Chang HY
Cell; 2018 May; 173(6):1398-1412.e22. PubMed ID: 29731168
[TBL] [Abstract][Full Text] [Related]
15. A pan-cancer analysis of MYC-PVT1 reveals CNV-unmediated deregulation and poor prognosis in renal carcinoma.
Posa I; Carvalho S; Tavares J; Grosso AR
Oncotarget; 2016 Jul; 7(30):47033-47041. PubMed ID: 27366943
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA PVT1 and cancer.
Cui M; You L; Ren X; Zhao W; Liao Q; Zhao Y
Biochem Biophys Res Commun; 2016 Feb; 471(1):10-4. PubMed ID: 26850852
[TBL] [Abstract][Full Text] [Related]
17. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.
Guan Y; Kuo WL; Stilwell JL; Takano H; Lapuk AV; Fridlyand J; Mao JH; Yu M; Miller MA; Santos JL; Kalloger SE; Carlson JW; Ginzinger DG; Celniker SE; Mills GB; Huntsman DG; Gray JW
Clin Cancer Res; 2007 Oct; 13(19):5745-55. PubMed ID: 17908964
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia.
Zeng C; Yu X; Lai J; Yang L; Chen S; Li Y
J Hematol Oncol; 2015 Nov; 8():126. PubMed ID: 26545364
[TBL] [Abstract][Full Text] [Related]
19. Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality.
Nagoshi H; Taki T; Hanamura I; Nitta M; Otsuki T; Nishida K; Okuda K; Sakamoto N; Kobayashi S; Yamamoto-Sugitani M; Tsutsumi Y; Kobayashi T; Matsumoto Y; Horiike S; Kuroda J; Taniwaki M
Cancer Res; 2012 Oct; 72(19):4954-62. PubMed ID: 22869583
[TBL] [Abstract][Full Text] [Related]
20. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
Parrella P; Caballero OL; Sidransky D; Merbs SL
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
